Securian Asset Management Inc. Sells 5,975 Shares of Agilent Technologies, Inc. $A

Securian Asset Management Inc. reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 43.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 7,708 shares of the medical research company’s stock after selling 5,975 shares during the quarter. Securian Asset Management Inc.’s holdings in Agilent Technologies were worth $1,049,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in A. Board of the Pension Protection Fund bought a new position in Agilent Technologies during the 4th quarter valued at about $27,000. Physician Wealth Advisors Inc. increased its stake in shares of Agilent Technologies by 490.0% in the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after buying an additional 196 shares in the last quarter. Torren Management LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at about $32,000. State of Wyoming bought a new stake in Agilent Technologies during the 2nd quarter worth about $35,000. Finally, Johnson Financial Group Inc. bought a new stake in shares of Agilent Technologies during the third quarter valued at approximately $49,000.

Agilent Technologies Stock Up 1.3%

Shares of Agilent Technologies stock opened at $112.93 on Wednesday. The company has a market capitalization of $31.91 billion, a P/E ratio of 24.93, a price-to-earnings-growth ratio of 2.35 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The business has a 50-day moving average of $115.46 and a two-hundred day moving average of $131.30. Agilent Technologies, Inc. has a 1 year low of $107.07 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter last year, the firm earned $1.31 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Analyst Ratings Changes

A has been the topic of a number of recent research reports. Wells Fargo & Company decreased their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Barclays dropped their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. UBS Group decreased their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Morgan Stanley dropped their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.